menu search

OTIC / Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript

Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript
Otonomy, Inc. (NASDAQ:OTIC ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Robert Uhl - IR David Weber - President, CEO and Director Paul Cayer - Chief Financial & Business Officer Conference Call Participants Ken Cacciatore - Cowen Chris Raymond - Piper Sandler Pete Stavropoulos - Cantor Fitzgerald Francois Brisebois - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the Otonomy First Quarter 2022 Financial Results Conference Call. Read More
Posted: May 9 2022, 22:21
Author Name: Seeking Alpha
Views: 110150

OTIC News  

Why Is Otonomy (OTIC) Stock Up 97% Today?

By InvestorPlace
November 29, 2022

Why Is Otonomy (OTIC) Stock Up 97% Today?

Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical company. Instead, it looks like traders have la more_horizontal

Otonomy, Inc. (OTIC) CEO Dave Weber on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
July 25, 2022

Otonomy, Inc. (OTIC) CEO Dave Weber on Q2 2022 Results - Earnings Call Transcript

Otonomy, Inc. (NASDAQ:OTIC ) Q2 2022 Earnings Conference Call July 25, 2022 4:30 PM ET Company Participants Robert Uhl - Managing Director, ICR Westwi more_horizontal

Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 9, 2022

Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript

Otonomy, Inc. (NASDAQ:OTIC ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Robert Uhl - IR David Weber - President, CEO more_horizontal

Otonomy: Hearing Loss And Tinnitus Data In 2022

By Seeking Alpha
April 4, 2022

Otonomy: Hearing Loss And Tinnitus Data In 2022

Data for OTO-413 in hearing loss is due early in Q2 2002. more_horizontal

Otonomy to Participate in Two Upcoming Investor Conferences

By GlobeNewsWire
February 28, 2022

Otonomy to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal

Otonomy to Participate in Two Upcoming Investor Conferences

By GlobeNewsWire
February 28, 2022

Otonomy to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal

Otonomy to Participate in Two Upcoming Investor Conferences

By GlobeNewsWire
February 28, 2022

Otonomy to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative the more_horizontal


Search within

Pages Search Results: